Definitive Contract 75A50123C00047

Award Date 9/30/23
Potential Completion Date 9/29/33
Potential Value $83M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Pittsburgh, PA 15260, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,712,387.00 definitive cost-no-fee contract awarded by the U.S. Army Medical Command (MEDCOM) to the University of Pittsburgh. The contract, titled "TATRC BA PROPOSAL #BA180061-TRAUMA CARE IN A RUCKSACK," is for research and development of a portable autonomous fluid, blood, vasoactive drug, and respiratory resuscitation device platform to provide prolonged field care and enroute care for trauma patients. The University of Pittsburgh has subcontracted with Carnegie Mellon...
The Department of the Army Medical Command awarded a $7,452,420.12 delivery order contract to the University of Pittsburgh to conduct research on "Resuscitation in Patients with TBI". The 6-year contract, awarded on September 25, 2017, does not have a set-aside designation and is scheduled to be completed by September 30, 2023. As a state-related research university, the University of Pittsburgh has an extensive history of supporting federal agencies such as the Department of...
This federal contract award is for the "Prehospital Airway Control Trial Base Award", a $11,501,177.70 delivery order contract awarded by the Defense Health Agency to the University of Pittsburgh. The contract does not have a set-aside designation. The contract involves a 5-year, multi-center clinical trial comparing standard airway management strategies to initial use of supraglottic airway devices for prehospital trauma patients. The trial will be conducted through the Linking...
This is a $3,554,795.00 definitive contract awarded by the Defense Health Agency to the University of Pittsburgh, a large public research university in Pennsylvania. The contract is for a semi-closed loop control cardiovascular resuscitation research project to support prolonged field care, which does not have a set-aside designation. As a prime contractor, the University of Pittsburgh will leverage its extensive biomedical research expertise and capabilities to conduct this work. This...
This is a $17,695,468.14 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to the University of Pittsburgh (Pitt). The contract is for "PEDIATRIC CIRCULATORY SUPPORT" research and does not have a set-aside designation. Pitt, a large non-profit research university, frequently partners with government agencies on federally funded research projects in biomedical sciences and other disciplines. This contract...
This is a $8,270,925.09 federal contract award from the U.S. Army Medical Command (MEDCOM) to the University of Pittsburgh. The contract supports a 4-year, multi-center, prehospital, randomized, double-blind clinical trial comparing fentanyl versus sub-dissociative ketamine for mortality, safety, and analgesia outcomes in trauma patients with compensated shock. The University of Pittsburgh is the prime contractor and has subcontracted with several other academic medical centers and research...
This federal contract award was issued by the Medical Command (MEDCOM), a component of the U.S. Department of Defense, to the University of Pittsburgh for funding under CLIN 0001. The $10,842,111.60 cost-no-fee delivery order has a period of performance through September 30, 2022 and does not have a set-aside designation. As a large public research university, the University of Pittsburgh conducts a wide range of federally funded biomedical and medical research. For this award, the University of...
This is a $782,037.07 definitive contract awarded by the Defense Health Agency (DHA) to the University of Pittsburgh for new research on a proposal under the FY14 Broad Agency Announcement (BAA) of the U.S. Army Medical Research and Materiel Command (MRMC). The contract has no set-aside designation and was awarded on September 30, 2015, with a completion date of May 3, 2017. The University of Pittsburgh, a large public research institution, frequently partners with government agencies on...
This is a delivery order awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to the University of Pittsburgh for the Lung Tissue Research Consortium (LTRC) Clinical Center. The order, valued at $124,488.98, covers the period from March 1, 2018, to February 28, 2019. The University of Pittsburgh is performing the work in Pittsburgh, Pennsylvania, and the contract does not have a set-aside designation. The University of Pittsburgh is a state-related...
This federal contract award, valued at $9,014,126.00, was issued by a U.S. government agency to the University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh. The contract is for biomedical research and does not have a set-aside designation. The University of Pittsburgh is a state-related research university that frequently partners with industry, other academic institutions, and federally funded research centers to conduct research...

This $82.82 million federal contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to the University of Pittsburgh. The contract aims to provide definitive evidence on the effectiveness, safety, and mechanisms of low titer group O whole blood (LTOWB) and tranexamic acid (TXA) as resuscitation strategies for the treatment of life-threatening bleeding secondary to traumatic injury in children. The contract involves clinical activities, including conducting a multicenter randomized clinical trial, as well as related regulatory activities like obtaining an Investigational New Drug (IND) from the FDA and securing single Institutional Review Board (IRB) approval. The contract does not have a set-aside designation. The University of Pittsburgh is the prime contractor, with several academic medical centers serving as subcontractors, including Oregon Health & Science University, University of Texas Health Science Center at Houston, University of Utah, Johns Hopkins University, Baylor College of Medicine, and University of Rochester. This contract supports ASPR's mission to advance medical countermeasures and preparedness for public health emergencies.

Generated 9/5/24, 9:13 AM